CompletedPHASE1, PHASE2NCT02099994

Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Oxford
Principal Investigator
Walter Jaoko
University of Nairobi
Intervention
Ad35-GRIN(biological)
Enrollment
72 enrolled
Eligibility
18-50 years · All sexes
Timeline
20142015

Study locations (1)

Collaborators

European and Developing Countries Clinical Trials Partnership (EDCTP) · International AIDS Vaccine Initiative · Karolinska Institutet · University of Nairobi · Ichor Medical Systems Incorporated

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02099994 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency

← Back to all trials